Celularity (CELU) Current Taxes (2019 - 2020)

Celularity (CELU) posted quarterly Current Taxes of $81701.0 for Q3 2020, down 21.66% quarter-over-quarter from $104284.0 in Q2 2020.

Celularity (CELU) Current Taxes (2019 - 2020) Analysis & Trends

Celularity (CELU) has reported Current Taxes for 2 consecutive years, with $81701.0 the latest figure, recorded in Q3 2020.

In Q3 2020, Current Taxes changed N/A year-over-year to $81701.0; the TTM figure through Sep 2020 stood at $81701.0 (changed N/A YoY), while the FY2019 annual figure was $18883.0, changed N/A from the prior year.
Current Taxes declined to $81701.0 in Q3 2020 per CELU's latest filing, from $104284.0 in the prior quarter.
Across five years, Current Taxes topped out at $116891.0 in Q2 2019 and bottomed at $18883.0 in Q4 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Vertex Pharmaceuticals	138.76 Bn	130.91 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	86.15 Bn	78.15 Bn	3.93 Bn	-
3	Argenx Se	64.45 Bn	59.27 Bn	1.37 Bn	49.00 Mn
4	Moderna	57.08 Bn	51.94 Bn	52.00 Mn	-
5	BeOne Medicines	42.08 Bn	36.99 Bn	1.53 Bn	76.32 Mn
6	Alnylam Pharmaceuticals	30.90 Bn	27.59 Bn	992.69 Mn	-
7	BioNTech SE	27.76 Bn	9.37 Bn	668.28 Mn	76.36 Mn
8	Insmed	27.45 Bn	26.29 Bn	358.27 Mn	-
9	Royalty Pharma	27.00 Bn	26.17 Bn	-	-
10	Celularity	19.71 Mn	13.54 Mn	-3.27 Mn	-

Download Data